Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P B Chappell

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Biological Psychiatry|June 5, 1999
Cerebrospinal fluid dynorphin A[1-8] and beta-endorphin levels in Tourette's syndrome are unalteredP J van Wattum, G M Anderson, P B Chappell, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|March 1, 1991
Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatmentR A King, M A Riddle, P B Chappell, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|March 14, 2000
Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot studyF R Sallee, R Kurlan, C G Goetz, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|March 1, 1994
Videotape tic counts in the assessment of Tourette's syndrome: stability, reliability, and validityP B Chappell, M T McSwiggan-Hardin, L Scahill, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|September 1, 1995
Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experienceP B Chappell, M A Riddle, L Scahill, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|September 1, 1995
Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary reportP J Lombroso, L Scahill, R A King, et al.
The American Journal of Psychiatry|June 30, 2001
A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorderL Scahill, P B Chappell, Y S Kim, et al.
Life Sciences|January 1, 1997
Assessment of diurnal variation of cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in healthy human femalesP D Kirwin, G M Anderson, P B Chappell, et al.
Advances in Neurology|January 1, 1992
Neuroendocrine and behavioral effects of naloxone in Tourette syndromeP B Chappell, J F Leckman, M A Riddle, et al.
Biological Psychiatry|April 4, 2000
Impaired prepulse inhibition of acoustic startle in schizophreniaA Parwani, E J Duncan, E Bartlett, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Biological Psychiatry|June 5, 1999
Cerebrospinal fluid dynorphin A[1-8] and beta-endorphin levels in Tourette's syndrome are unalteredP J van Wattum, G M Anderson, P B Chappell, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|March 1, 1991
Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatmentR A King, M A Riddle, P B Chappell, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|March 14, 2000
Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot studyF R Sallee, R Kurlan, C G Goetz, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|March 1, 1994
Videotape tic counts in the assessment of Tourette's syndrome: stability, reliability, and validityP B Chappell, M T McSwiggan-Hardin, L Scahill, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|September 1, 1995
Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experienceP B Chappell, M A Riddle, L Scahill, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|September 1, 1995
Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary reportP J Lombroso, L Scahill, R A King, et al.
The American Journal of Psychiatry|June 30, 2001
A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorderL Scahill, P B Chappell, Y S Kim, et al.
Life Sciences|January 1, 1997
Assessment of diurnal variation of cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in healthy human femalesP D Kirwin, G M Anderson, P B Chappell, et al.
Advances in Neurology|January 1, 1992
Neuroendocrine and behavioral effects of naloxone in Tourette syndromeP B Chappell, J F Leckman, M A Riddle, et al.
Biological Psychiatry|April 4, 2000
Impaired prepulse inhibition of acoustic startle in schizophreniaA Parwani, E J Duncan, E Bartlett, et al.
Pageof 3